While the tumor-modulatory role of DYRK3 has been demonstrated in a limited number of recent studies, the detailed mechanisms underlying how DYRK3 affects the development of various types of cancers and its downstream substrates have not been extensively investigated. The gene discussed is DYRK3; the disease is neoplasm.